Chemed Sees FY24 EPS $23.00-$23.15 Vs $23.58 Est.
Portfolio Pulse from Benzinga Newsdesk
Chemed Corporation has revised its FY24 EPS guidance to a range of $23.00-$23.15, which is below the previous estimate of $23.58.
October 29, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Chemed Corporation has lowered its FY24 EPS guidance to $23.00-$23.15, which is below the market estimate of $23.58. This revision may indicate potential challenges in meeting earnings expectations.
The downward revision of EPS guidance suggests that Chemed may face challenges in achieving previously expected earnings levels. This could lead to negative sentiment among investors, potentially putting downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100